Welcome to AB Biosciences


Next generation CAR-T modules.

Engineering of the next generation CAR-T molecules: combination of a novel extracellular antigen binding domain and unique paired intracellular signaling modules is expected to lead to enhanced target specificity as well as long term survival of the activated cytotoxic T lymphocytes.


If you are interested in NeoCART project, please feel free to contact us for further discussion!


Recombinant protein as a Pan Fc Receptor Interacting molecule


Cancer treatment via symbiosis with tumor tissues through slowing down the progression of cancer-triggered cachexia.


Massive antibody mining, an unique platform for accelerating R&D timelines of therapeutic antibodies.


a Non-Antibody Biologics engineered for Blocking of SARS-CoV-2 Binding to ACE2.


Next generation CAR-T modules.

Déjà vu Mab

Niche platform technology for life cycle maintenance of approved antibody drugs.